top of page



Case Approach to Peri-operative Drug-Drug Interactions (Cover Editor) 

Moore C, Dull RO. (2011). Pharmacogenomics.

Galaviz C, Dull RO. (2011). A Curious Cause of Seizures.

Coyle D, Dull RO. (2011). P-glycoprotein and OATP

Coyle D, Dull RO. (2011). Cytochrome 2B

Thomas K, Dull RO. (2011). Drug-drug interactions: An Introduction.

DeCou J, Birgenheier N, Dull RO. (2011). CYP3A4

Baker D, Ogden LL, Dull RO. (2011). Induction Crashes: Are there clues in the ashes?

Fergerson B, Wallentine C, Dull RO. (2011). CYP2C9 Pharmacogenomics.

Gmelch B, Dull RO. (2014). CYP 2E

Larson A, Dull RO. (2014). Pro-drugs in Anesthesia Practice

Rousell D, Hagn E, Dull RO. (2014). CYP1A2

Sanders JC, Koll R, Dull RO (2014). CYP2D6

Jericho B, Aguiar A, Dull RO. (2014). CYP 2C19

Goldschmidt T, Dull RO. (2014). DDI: Anti-seizure medications and the duration of
neuromuscular blockade.

Nixon H, Dull RO. (2014). DDI and the P-glycoprotein transporters: St. John’s Wort and
spinal opiates.

Quadri S, Dull RO. (2014). DDI: Extended release opiates pharmacodynamics of
propofol and benzodiazipines.


Pontinen T, Dull RO. (2014). DDI and the P-glycoprotein transporters: Rifampin and
oral morphine.

Chovatiya R, Dull RO. (2014). P-glycoprotein transporters: methadone influence on
substrate transport.

Nwazota N, Dull RO. (2014). P-glycoprotein transporters: Nicardipine and anesthetic
drug transport.

Canelas AM, Dull RO. (2014). Neostigmine and neuromuscular blocking drugs: timing
of reversal and pharmacodynamics effects.

Canelas AM, Dull RO. (2009). Plavix-Omeprazole Interaction: The way to a man’s
heart really is through his stomach.


bottom of page